{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:29:45Z","timestamp":1792466985132,"version":"4.5.0"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UK Department of Health and Social Care"},{"name":"Fleming Fund","award":["R52354 CN001"],"award-info":[{"award-number":["R52354 CN001"]}]},{"name":"UK National Institute for Health and Care Research","award":["NIHR305136"],"award-info":[{"award-number":["NIHR305136"]}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR HealthTech Research Centre"},{"name":"In Vitro Diagnostics"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This paper builds on the other papers in this series to present high-level lessons learnt and considerations for the future of antimicrobial resistance (AMR) surveillance and its contribution to action on AMR in low- and middle-income countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Participatory synthesis involved engagement with individuals who had worked within and alongside the Fleming Fund from a range of organizations and geographies, to scope and solidify lessons learnt and future considerations relevant to a wide range of donors, partners, and policy makers or implementors. Contributors were invited to join a Writing Group, which included individuals from academia, clinical sciences, applied public, animal, environment, and food sciences health, as well as senior scientists and administrators from 14 organizations. The synthesis was informed by contributions to 4 virtual workshops and 3 drafts of the manuscript. Authors read and commented on the drafts, several wrote and referenced sections, and all gave substantive feedback with their reactions to the draft conclusions as consensus was built.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Over nearly 10 years, the Fleming Fund achieved significant improvements in AMR surveillance. Analysis of the barriers and enablers across settings and systems highlights key lessons for how surveillance is positioned, funded, used, and innovated upon. The success of future AMR surveillance and its sustainability relies on planning within resource constraints for a sharpened system that focuses the scope, frequency, and depth of data to inform action, technical, and architectural developments directions to streamline investment and financing that supports country-led sustainable approaches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Investment in AMR surveillance and broader AMR actions has yielded substantial progress. Expanded domestic public financing, large-scale private sector engagement, or enhanced multilateral support will be needed to ensure recent gains are sustained. Progress will require well-designed, targeted, and cost-effective investments to maintain current capacity while enabling further system strengthening.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciag498","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:29:50Z","timestamp":1792423790000},"page":"S60-S71","source":"Crossref","is-referenced-by-count":1,"title":["Reflections for the Future of AMR Surveillance and AMR Action"],"prefix":"10.1093","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6499-7522","authenticated-orcid":false,"given":"Clare I R","family":"Chandler","sequence":"first","affiliation":[{"name":"London School of Hygiene and Tropical Medicine ,","place":["United Kingdom"]},{"name":"Fleming Fund Technical Advisory Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Abbas","sequence":"additional","affiliation":[{"name":"Institute of Development Studies, University of Sussex ,","place":["United Kingdom"]},{"name":"Itad Ltd, Independent Consultant, International House, Queens Road, Brighton ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afreenish","family":"Amir","sequence":"additional","affiliation":[{"name":"Fleming Fund Technical Advisory Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Bertagnolio","sequence":"additional","affiliation":[{"name":"Department of Antimicrobial Resistance, World Health Organization"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Bibangamba","sequence":"additional","affiliation":[{"name":"Fleming Fund management agent, Mott MacDonald, London ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Brown","sequence":"additional","affiliation":[{"name":"UK Health Security Agency"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Brown","sequence":"additional","affiliation":[{"name":"Itad Ltd, Independent Consultant, International House, Queens Road, Brighton ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick M","family":"Card","sequence":"additional","affiliation":[{"name":"Animal and Plant Health Agency"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Chattoe-Brown","sequence":"additional","affiliation":[{"name":"Fleming Fund management agent, Mott MacDonald, London ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Dalton","sequence":"additional","affiliation":[{"name":"Food and Agricultural Organization"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archie","family":"Drake","sequence":"additional","affiliation":[{"name":"Itad Ltd, Independent Consultant, International House, Queens Road, Brighton ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Fenwick","sequence":"additional","affiliation":[{"name":"Fleming Fund management agent, Mott MacDonald, London ,","place":["United Kingdom"]},{"name":"College of Environmental and Life Sciences, Murdoch University ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Gilbert","sequence":"additional","affiliation":[{"name":"Veterinary Medicines Directorate"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Gordon","sequence":"additional","affiliation":[{"name":"Fleming Fund Technical Advisory Group"},{"name":"UK Health Security Agency"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Gupta-Wright","sequence":"additional","affiliation":[{"name":"Itad Ltd, Independent Consultant, International House, Queens Road, Brighton ,","place":["United Kingdom"]},{"name":"Department of Infectious Disease, Imperial College London ,","place":["United Kingdom"]},{"name":"Department of Infectious Diseases and Tropical Medicine, University of Heidelberg ,","place":["Germany"]},{"name":"Department of Infectious Diseases, North Bristol NHS Trust , Bristol ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1076-6758","authenticated-orcid":false,"given":"Heidi","family":"Hopkins","sequence":"additional","affiliation":[{"name":"Fleming Fund management agent, Mott MacDonald, London ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Kabali","sequence":"additional","affiliation":[{"name":"Food and Agricultural Organization"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2277-9572","authenticated-orcid":false,"given":"Freddy","family":"Kitutu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Makerere University School of Health Sciences, Kampala ,","place":["Uganda"]},{"name":"Department of Women's and Children's Health, International Child Health and Migration, Uppsala University, SE-751 85 Uppsala ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Leslie","sequence":"additional","affiliation":[{"name":"Fleming Fund management agent, Mott MacDonald, London ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8900-2138","authenticated-orcid":false,"given":"Rebecca","family":"Maudling","sequence":"additional","affiliation":[{"name":"Itad Ltd, Independent Consultant, International House, Queens Road, Brighton ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxencia","family":"Nabiryo","sequence":"additional","affiliation":[{"name":"Commonwealth Pharmacists Association"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Potter","sequence":"additional","affiliation":[{"name":"Foreign Commonwealth & Development Office ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Rosado","sequence":"additional","affiliation":[{"name":"Commonwealth Pharmacists Association"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Rutter","sequence":"additional","affiliation":[{"name":"Commonwealth Pharmacists Association"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Shetty","sequence":"additional","affiliation":[{"name":"Department of Health and Social Care ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0792-660X","authenticated-orcid":false,"given":"Tim","family":"Shorten","sequence":"additional","affiliation":[{"name":"Itad Ltd, Independent Consultant, International House, Queens Road, Brighton ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7314-9346","authenticated-orcid":false,"given":"Milena","family":"von und zur M\u00fchlen","sequence":"additional","affiliation":[{"name":"Department of Health and Social Care ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona","family":"Waddington","sequence":"additional","affiliation":[{"name":"Fleming Fund Expert Advisory Group ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap A","family":"Wagenaar","sequence":"additional","affiliation":[{"name":"Fleming Fund Technical Advisory Group"},{"name":"Division of Infectious Diseases & Immunology, Faculty of Veterinary Medicine, Utrecht University ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Wesangula","sequence":"additional","affiliation":[{"name":"Itad Ltd, Independent Consultant, International House, Queens Road, Brighton ,","place":["United Kingdom"]},{"name":"Family Health and Infectious Diseases, East Central and Southern Africa Health Community, Arusha , Arusha ,","place":["Tanzania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Whitaker","sequence":"additional","affiliation":[{"name":"Itad Ltd, Independent Consultant, International House, Queens Road, Brighton ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Yugueros-Marcos","sequence":"additional","affiliation":[{"name":"World Organization for Animal Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3946-8734","authenticated-orcid":false,"given":"Kate","family":"Macintyre","sequence":"additional","affiliation":[{"name":"Itad Ltd, Independent Consultant, International House, Queens Road, Brighton ,","place":["United Kingdom"]},{"name":"Oxford Health Evaluations , Buckingham ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"key":"2026101911294238100_ciag498-B1","volume-title":"Independent evaluation of the Fleming Fund phase 2: 2024 progress report on results to date and phase 2 design","author":"Itad","year":"2024"},{"key":"2026101911294238100_ciag498-B2","first-page":"S3","article-title":"The Fleming Fund: key features of design and approach to strengthening antimicrobial resistance surveillance in low- and middle-income countries","volume":"83","author":"Shorten","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026101911294238100_ciag498-B3","doi-asserted-by":"crossref","DOI":"10.48060\/tghn.189","volume-title":"Optimising AMR surveillance in animal health: a case study review","author":"Worth","year":"2026"},{"key":"2026101911294238100_ciag498-B4","author":"World Health Organization"},{"key":"2026101911294238100_ciag498-B5","volume-title":"The International FAO Antimicrobial Resistance Monitoring (InFARM) system\u2014manual for implementation 2024","author":"Food and Agriculture Organization","year":"2024"},{"key":"2026101911294238100_ciag498-B6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.20506\/rst.42.3363","article-title":"Antimicrobial use in animals: a journey towards integrated surveillance","volume":"42","author":"Jeannin","year":"2023","journal-title":"Rev Sci Tech"},{"key":"2026101911294238100_ciag498-B7","volume-title":"Ethics and drug resistance: collective responsibility for global public health. Public health ethics analysis, vol 5","author":"Littmann","year":"2020"},{"key":"2026101911294238100_ciag498-B8","volume-title":"AMR And the need for new and old treatments for drug-resistant infections in LMICs. In: GARDP antimicrobial viewpoints","author":"Kariuki","year":"2024"},{"key":"2026101911294238100_ciag498-B9","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050","volume":"404","author":"GBD 2021 Antimicrobial Resistance Collaborators","year":"2024","journal-title":"The Lancet"},{"key":"2026101911294238100_ciag498-B10","volume-title":"Forecasting the fallout from AMR: averting the health and economic impacts through One Health policy and investment\u2014a policy brief from the EcoAMR series","author":"World Organisation for Animal Health","year":"2024"},{"key":"2026101911294238100_ciag498-B11","volume-title":"Forecasting the fallout from AMR","author":"McDonnell","year":"2024"},{"key":"2026101911294238100_ciag498-B12","author":"World Health Organization"},{"key":"2026101911294238100_ciag498-B13","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1038\/s41467-025-64137-z","article-title":"Antimicrobial resistance, equity and justice in low- and middle-income countries: an intersectional critical interpretive synthesis","volume":"16","author":"Davis","year":"2025","journal-title":"Nat Commun"},{"key":"2026101911294238100_ciag498-B14","doi-asserted-by":"crossref","first-page":"2542400","DOI":"10.1080\/17441692.2025.2542400","article-title":"The role of gender in antimicrobial resistance: findings from a scoping review","volume":"20","author":"Ruckert","year":"2025","journal-title":"Glob Public Health"},{"key":"2026101911294238100_ciag498-B15","doi-asserted-by":"crossref","first-page":"e1004579","DOI":"10.1371\/journal.pmed.1004579","article-title":"Combining demographic shifts with age-based resistance prevalence to estimate future antimicrobial resistance burden in Europe and implications for targets: a modelling study","volume":"22","author":"Waterlow","year":"2025","journal-title":"PLoS Med"},{"key":"2026101911294238100_ciag498-B16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1057\/s41599-018-0152-2","article-title":"Pharming animals: a global history of antibiotics in food production (1935\u20132017)","volume":"4","author":"Kirchhelle","year":"2018","journal-title":"Palgrave Commun"},{"key":"2026101911294238100_ciag498-B17","volume-title":"Global action plan on antimicrobial resistance","author":"World Health Organization","year":"2015"},{"key":"2026101911294238100_ciag498-B18","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(15)00755-2","article-title":"Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from disease control priorities, 3rd edition","volume":"387","author":"Gelband","year":"2016","journal-title":"The Lancet"},{"key":"2026101911294238100_ciag498-B19","doi-asserted-by":"crossref","first-page":"e0000018","DOI":"10.1371\/journal.pgph.0000018","article-title":"Antimicrobial resistance detection in southeast Asian hospitals is critically important from both patient and societal perspectives, but what is its cost?","volume":"1","author":"Roberts","year":"2021","journal-title":"PLOS Glob Public Health"},{"key":"2026101911294238100_ciag498-B20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12961-023-01087-2","article-title":"Producing knowledge together: a participatory approach to synthesising research across a large-scale collaboration in Aboriginal and Torres Strait Islander health","volume":"22","author":"Conte","year":"2024","journal-title":"Health Res Policy Syst"},{"key":"2026101911294238100_ciag498-B21","author":"African Society for Laboratory Medicine"},{"key":"2026101911294238100_ciag498-B22","author":"United Nations General Assembly"},{"key":"2026101911294238100_ciag498-B23","volume-title":"Quadripartite guidance on One Health integrated surveillance of antimicrobial resistance and use","author":"Quadripartite Joint Secretariat on Antimicrobial Resistance","year":"2026"},{"key":"2026101911294238100_ciag498-B24","article-title":"Tackling drug-resistant infections globally: final report and recommendations","author":"O\u2019Neill","year":"2016","journal-title":"Rev Antimicrob Resistance"},{"key":"2026101911294238100_ciag498-B25","doi-asserted-by":"crossref","first-page":"e690","DOI":"10.1016\/S2214-109X(26)00008-2","article-title":"Impact of two decades of humanitarian and development assistance and the projected mortality consequences of current defunding to 2030: retrospective evaluation and forecasting analysis","volume":"14","author":"da Silva","year":"2026","journal-title":"Lancet Glob Health"},{"key":"2026101911294238100_ciag498-B26","doi-asserted-by":"crossref","first-page":"e256","DOI":"10.1016\/S1473-3099(25)00209-9","article-title":"Threat of HIV and tuberculosis drug resistance after US funding cuts","volume":"25","author":"McClure","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"2026101911294238100_ciag498-B27","doi-asserted-by":"crossref","first-page":"101625","DOI":"10.1016\/j.nmni.2025.101625","article-title":"The discontinuation of the Fleming Fund: implications for global mitigation of antimicrobial resistance","volume":"67","author":"Ashinze","year":"2025","journal-title":"New Microbes New Infect"},{"key":"2026101911294238100_ciag498-B28","volume-title":"Investment case: eighth replenishment 2025","author":"The Global Fund","year":"2025"},{"key":"2026101911294238100_ciag498-B29","volume-title":"The pandemic fund and antimicrobial resistance","author":"The Pandemic Fund","year":"2024"},{"key":"2026101911294238100_ciag498-B30","author":"Food and Agriculture Organization"},{"key":"2026101911294238100_ciag498-B31","doi-asserted-by":"crossref","DOI":"10.48060\/tghn.204","volume-title":"Sustaining AMR surveillance beyond the Fleming Fund: an analysis of enablers and blockers","author":"Palmer","year":"2025"},{"key":"2026101911294238100_ciag498-B32","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1093\/cid\/ciag517","article-title":"Antimicrobial resistance and one health: lessons on one health governance and implementation from the Fleming fund","volume":"83","author":"Abbas","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026101911294238100_ciag498-B33","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/S1473-3099(24)00649-2","article-title":"Sustainable antimicrobial resistance surveillance: time for a global funding mechanism","volume":"25","author":"Painter","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"2026101911294238100_ciag498-B34","author":"Accra Reset"},{"key":"2026101911294238100_ciag498-B35","author":"Kerry"},{"key":"2026101911294238100_ciag498-B36","volume-title":"Paris Declaration on aid effectiveness","author":"Organisation for Economic Co-operation and Development","year":"2005"},{"key":"2026101911294238100_ciag498-B37","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/cid\/ciag497","article-title":"Generating actionable data from Antimicrobial Resistance Surveillance: insights from the Fleming Fund's international experience","volume":"83","author":"Gupta-Wright","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026101911294238100_ciag498-B38","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1093\/cid\/ciag520","article-title":"Surveillance data use through the Fleming Fund: informing action on Antimicrobial Resistance in low- and middle-income countries","volume":"83","author":"Drake","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026101911294238100_ciag498-B39","article-title":"Integrated surveillance of antimicrobial resistance (AMR) and use (AMU): a pocket guide for political decision-makers","author":"Quadripartite Joint Secretariat on Antimicrobial Resistance","year":"2023","journal-title":"Quadripartite Joint Secretariat on Antimicrob Resistance"},{"key":"2026101911294238100_ciag498-B40","first-page":"55","article-title":"Antibiotic surveillance: an action-oriented integrated approach","volume":"11","author":"Valsson","year":"2026","journal-title":"Wellcome Open Res"},{"key":"2026101911294238100_ciag498-B41","volume-title":"WHO Strategic and technical advisory group for antimicrobial resistance (STAG-AMR): report of the second meeting, 14\u201316 June 2022","author":"World Health Organization","year":"2022"},{"key":"2026101911294238100_ciag498-B42","doi-asserted-by":"crossref","first-page":"e017389","DOI":"10.1136\/bmjgh-2024-017389","article-title":"The intersection of the social determinants of health and antimicrobial resistance in human populations: a systematic review","volume":"10","author":"Shutt","year":"2025","journal-title":"BMJ Glob Health"},{"key":"2026101911294238100_ciag498-B43","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jgar.2026.01.001","article-title":"Deconstructing antimicrobial resistance national action plans: a gender-perspective driven mixed-methods analysis","volume":"46","author":"Gatsch","year":"2026","journal-title":"J Glob Antimicrob Resist"},{"key":"2026101911294238100_ciag498-B44","author":"Global Research on Antimicrobial Resistance Project"},{"key":"2026101911294238100_ciag498-B45","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/S0140-6736(25)00804-9","article-title":"Moving the dial on diagnostics: an update from the Lancet Commission on diagnostics","volume":"405","author":"Horton","year":"2025","journal-title":"The Lancet"},{"key":"2026101911294238100_ciag498-B46","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1016\/S1473-3099(25)00313-5","article-title":"Artificial intelligence and infectious diseases: tackling antimicrobial resistance, from personalised care to antibiotic discovery","volume":"26","author":"Howard","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"2026101911294238100_ciag498-B47","doi-asserted-by":"crossref","first-page":"1716498","DOI":"10.3389\/fpubh.2025.1716498","article-title":"SeqAfrica: empowering Africa's fight against antimicrobial resistance through genomics","volume":"13","author":"Nilsson","year":"2025","journal-title":"Front Public Health"},{"key":"2026101911294238100_ciag498-B48","doi-asserted-by":"crossref","first-page":"e002244","DOI":"10.1136\/bmjgh-2019-002244","article-title":"Whole-genome sequencing as part of national and international surveillance programmes for antimicrobial resistance: a roadmap","volume":"5","author":"NIHR Global Health Research Unit on Genomic Surveillance of AMR","year":"2020","journal-title":"BMJ Glob Health"},{"key":"2026101911294238100_ciag498-B49","doi-asserted-by":"crossref","first-page":"e003622","DOI":"10.1136\/bmjgh-2020-003622","article-title":"Leapfrogging laboratories: the promise and pitfalls of high-tech solutions for antimicrobial resistance surveillance in low-income settings","volume":"5","author":"Okeke","year":"2020","journal-title":"BMJ Glob Health"},{"key":"2026101911294238100_ciag498-B50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2991\/dsahmj.k.190225.001","article-title":"Essential diagnostics: a key element of universal health coverage","volume":"1","author":"Pai","year":"2019","journal-title":"Dr Sulaiman Al Habib Med J"},{"key":"2026101911294238100_ciag498-B51","author":"Quadripartite Joint Secretariat on Antimicrobial Resistance"},{"key":"2026101911294238100_ciag498-B52","doi-asserted-by":"crossref","first-page":"106159","DOI":"10.1016\/j.puhe.2026.106159","article-title":"Global policy review to identify links between climate change and antimicrobial resistance","volume":"253","author":"Thornton","year":"2026","journal-title":"Public Health"},{"key":"2026101911294238100_ciag498-B53","article-title":"The state of the World's Animal Health 2026","author":"World Organisation for Animal Health","year":"2026","journal-title":"WOAH."},{"key":"2026101911294238100_ciag498-B54","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1126\/science.adj5918","article-title":"Unlock the potential of vaccines in food-producing animals","volume":"384","author":"Laxminarayan","year":"2024","journal-title":"Science"},{"key":"2026101911294238100_ciag498-B55","doi-asserted-by":"crossref","first-page":"20250009","DOI":"10.1098\/rstb.2025.0009","article-title":"Animal vaccines and antimicrobial resistance: an underutilized tool","volume":"381","author":"Yugueros-Marcos","year":"2026","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"2026101911294238100_ciag498-B56","author":"The Fleming Fund"},{"key":"2026101911294238100_ciag498-B57","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1093\/cid\/ciag500","article-title":"Fleming Fund implementation in Kenya: what have we learned about strengthening one health Antimicrobial Resistance Surveillance for decision-making?","volume":"83","author":"Wesangula","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026101911294238100_ciag498-B58","volume-title":"Results report 2025: summary and key results","author":"The Global Fund","year":"2025"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/83\/Supplement_1\/S60\/72114909\/ciag498.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/83\/Supplement_1\/S60\/72114909\/ciag498.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:29:57Z","timestamp":1792423797000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/83\/Supplement_1\/S60\/8943557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":58,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2026,10,19]]},"published-print":{"date-parts":[[2026,10,19]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciag498","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10,15]]},"published":{"date-parts":[[2026,10,15]]}}}